Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3-MAML2 fusions.

Yoshihide OkumuraTakayuki MuraseKosuke SaidaKana FujiiHisashi TakinoAyako MasakiKei IjichiKazuo ShimozatoYuichiro TadaKen-Ichi NibuHiroshi Inagaki

Published in: Head & neck (2018)

An excellent prognosis may be achieved without PORT in T1/2N0M0 mucoepidermoid carcinoma patients positive for CRTC1/3-MAML2 fusions when the tumors are completely resected without tumor spillage.

Keyphrases

end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
early stage
peritoneal dialysis
radiation therapy
patient reported outcomes
minimally invasive